Selective norepinephrine reuptake inhibitor antidepressants such as bupropion and venlafaxine, alpha-2 agonists such as clonidine and guanfacine, and other psychoactive drugs are sometimes used in cases of stimulant drug ineffectiveness or unacceptable adverse effects, but they are less effective and are not recommended as first-line drugs.